Jan 19, 2026 · Tirzepatide, marketed as Mounjaro and recently also as Zepbound specifically for weight management, was approved for type 2 diabetes in 2022 and for weight management in 2023.

Dec 2, 2025 · Tirzepatide (Zepbound brand) is a once-weekly injection used for weight loss, weight management, and weight-related conditions, including obstructive sleep apnea (OSA).

Tirzepatide is a gastric inhibitory polypeptide (GIP) analog and a GLP-1 receptor agonist. [10] The most common side effects include nausea, vomiting, diarrhea, decreased appetite, constipation, upper …

This site provides information about Mounjaro ® (tirzepatide) and Zepbound ® (tirzepatide), our prescription-only, FDA-approved medicines containing tirzepatide.

Feb 1, 2026 · Tirzepatide injection is used to treat type 2 diabetes. It is used together with diet and exercise to help control your blood sugar. Tirzepatide is a glucose-dependent insulinotropic …

Mounjaro (tirzepatide) helps manage blood sugar in people with Type 2 diabetes. It also helps with weight loss. It’s an injection you take once every seven days.

Dec 27, 2024 · Find patient medical information for Zepbound (tirzepatide) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Jan 13, 2025 · Tirzepatide is a prescription medication indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Jun 4, 2022 · Tirzepatide is a once-weekly subcutaneous injectable peptide (approved by the Food and Drug Administration [FDA] for type 2 diabetes) engineered from the native GIP sequence, with agonist...

Tirzepatide is in a class of medications called incretin mimetics. It works by helping the pancreas to release the right amount of insulin when blood sugar levels are high.